Table of Contents 1 Market Overview 1.1 Peptide Cancer Vaccine Introduction 1.2 Market Analysis by Type 1.3 Market Analysis by Applications 1.3.1 Breast Cancer 1.3.2 Lung Cancer 1.3.3 Melanoma 1.3.4 Prostate Cancer 1.3.5 Others 1.4 Market Analysis by Countries 1.4.1 Germany Status and Prospect (2013-2023) 1.4.2 France Status and Prospect (2013-2023) 1.4.3 UK Status and Prospect (2013-2023) 1.4.4 Russia Status and Prospect (2013-2023) 1.4.5 Italy Status and Prospect (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 TapImmune 2.1.1 Business Overview 2.1.2 Peptide Cancer Vaccine Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 TapImmune Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 BrightPath Biotherapeutics 2.2.1 Business Overview 2.2.2 Peptide Cancer Vaccine Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 BrightPath Biotherapeutics Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Ultimovacs 2.3.1 Business Overview 2.3.2 Peptide Cancer Vaccine Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Ultimovacs Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Sellas 2.4.1 Business Overview 2.4.2 Peptide Cancer Vaccine Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Sellas Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Boston Biomedical 2.5.1 Business Overview 2.5.2 Peptide Cancer Vaccine Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 Boston Biomedical Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Imugene 2.6.1 Business Overview 2.6.2 Peptide Cancer Vaccine Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Imugene Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 VAXON Biotech 2.7.1 Business Overview 2.7.2 Peptide Cancer Vaccine Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 VAXON Biotech Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Generex Biotechnology 2.8.1 Business Overview 2.8.2 Peptide Cancer Vaccine Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 Generex Biotechnology Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 ISA Pharmaceuticals 2.9.1 Business Overview 2.9.2 Peptide Cancer Vaccine Type and Applications 2.9.2.1 Type 1 2.9.2.2 Type 2 2.9.3 ISA Pharmaceuticals Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 OncoTherapy Science 2.10.1 Business Overview 2.10.2 Peptide Cancer Vaccine Type and Applications 2.10.2.1 Type 1 2.10.2.2 Type 2 2.10.3 OncoTherapy Science Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.11 Immatics 2.11.1 Business Overview 2.11.2 Peptide Cancer Vaccine Type and Applications 2.11.2.1 Type 1 2.11.2.2 Type 2 2.11.3 Immatics Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Europe Peptide Cancer Vaccine Market Competition, by Manufacturer 3.1 Europe Peptide Cancer Vaccine Sales and Market Share by Manufacturer (2016-2017) 3.2 Europe Peptide Cancer Vaccine Revenue and Market Share by Manufacturer (2016-2017) 3.3 Europe Peptide Cancer Vaccine Price by Manufacturers (2016-2017) 3.4 Market Concentration Rate 3.4.1 Top 3 Peptide Cancer Vaccine Manufacturer Market Share (2016-2017) 3.4.2 Top 5 Peptide Cancer Vaccine Manufacturer Market Share (2016-2017) 3.5 Market Competition Trend 4 Europe Peptide Cancer Vaccine Market Analysis by Countries (2013-2018) 4.1 Europe Peptide Cancer Vaccine Sales by Countries (2013-2018) 4.2 Europe Peptide Cancer Vaccine Sales Market Share by Countries (2013-2018) 4.3 Europe Peptide Cancer Vaccine Revenue (Value) and Market Share by Countries (2013-2018) 4.3.1 Europe Peptide Cancer Vaccine Revenue by Countries (2013-2018) 4.3.2 Europe Peptide Cancer Vaccine Revenue Market Share by Countries (2013-2018) 5 Europe Market Segmentation Peptide Cancer Vaccine by Type 5.1 Europe Peptide Cancer Vaccine Sales, Revenue and Market Share by Type (2013-2018) 5.1.1 Europe Peptide Cancer Vaccine Sales and Market Share by Type (2013-2018) 5.1.2 Europe Peptide Cancer Vaccine Revenue and Market Share by Type (2013-2018) 6 Europe Market Segmentation Peptide Cancer Vaccine by Application 6.1 Europe Peptide Cancer Vaccine Sales Market Share by Application (2013-2018) 6.2 Breast Cancer Sales Growth (2013-2018) 6.3 Lung Cancer Sales Growth (2013-2018) 6.4 Melanoma Sales Growth (2013-2018) 6.5 Prostate Cancer Sales Growth (2013-2018) 6.6 Others Sales Growth (2013-2018) 7 Germany Peptide Cancer Vaccine Sales, Revenue, by Type, Application and Manufacturers 7.1 Germany Peptide Cancer Vaccine Revenue, Sales and Growth Rate (2013-2018) 7.2 Germany Peptide Cancer Vaccine Sales and Market Share by Type (2013-2018) 7.2.1 Germany Peptide Cancer Vaccine Sales by Type (2013-2018) 7.2.2 Germany Peptide Cancer Vaccine Sales Market Share by Type (2013-2018) 7.3 Germany Peptide Cancer Vaccine Sales and Market Share by Application (2013-2018) 7.3.1 Germany Peptide Cancer Vaccine Sales by Application (2013-2018) 7.3.2 Germany Peptide Cancer Vaccine Sales Market Share by Application (2013-2018) 7.4 Germany Peptide Cancer Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017) 7.4.1 Germany Peptide Cancer Vaccine Sales and Market Share by Manufacturer (2016-2017) 7.4.2 Germany Peptide Cancer Vaccine Revenue and Market Share by Manufacturer (2016-2017) 7.5 Germany Peptide Cancer Vaccine Export and Import (2013-2018) 8 UK Peptide Cancer Vaccine Sales, Revenue, by Type, Application and Manufacturers 8.1 UK Peptide Cancer Vaccine Revenue, Sales and Growth Rate (2013-2018) 8.2 UK Peptide Cancer Vaccine Sales and Market Share by Type (2013-2018) 8.2.1 UK Peptide Cancer Vaccine Sales by Type (2013-2018) 8.2.2 UK Peptide Cancer Vaccine Sales Market Share by Type (2013-2018) 8.3 UK Peptide Cancer Vaccine Sales and Market Share by Application (2013-2018) 8.3.1 UK Peptide Cancer Vaccine Sales by Application (2013-2018) 8.3.2 UK Peptide Cancer Vaccine Sales Market Share by Application (2013-2018) 8.4 UK Peptide Cancer Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017) 8.4.1 UK Peptide Cancer Vaccine Sales and Market Share by Manufacturer (2016-2017) 8.4.2 UK Peptide Cancer Vaccine Revenue and Market Share by Manufacturer (2016-2017) 8.5 UK Peptide Cancer Vaccine Export and Import (2013-2018) 9 France Peptide Cancer Vaccine Sales, Revenue, by Type, Application and Manufacturers 9.1 France Peptide Cancer Vaccine Revenue, Sales and Growth Rate (2013-2018) 9.2 France Peptide Cancer Vaccine Sales and Market Share by Type (2013-2018) 9.2.1 France Peptide Cancer Vaccine Sales by Type (2013-2018) 9.2.2 France Peptide Cancer Vaccine Sales Market Share by Type (2013-2018) 9.3 France Peptide Cancer Vaccine Sales and Market Share by Application (2013-2018) 9.3.1 France Peptide Cancer Vaccine Sales by Application (2013-2018) 9.3.2 France Peptide Cancer Vaccine Sales Market Share by Application (2013-2018) 9.4 France Peptide Cancer Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017) 9.4.1 France Peptide Cancer Vaccine Sales and Market Share by Manufacturer (2016-2017) 9.4.2 France Peptide Cancer Vaccine Revenue and Market Share by Manufacturer (2016-2017) 9.5 France Peptide Cancer Vaccine Export and Import (2013-2018) 10 Russia Peptide Cancer Vaccine Sales, Revenue, by Type, Application and Manufacturers 10.1 Russia Peptide Cancer Vaccine Revenue, Sales and Growth Rate (2013-2018) 10.2 Russia Peptide Cancer Vaccine Sales and Market Share by Type (2013-2018) 10.2.1 Russia Peptide Cancer Vaccine Sales by Type (2013-2018) 10.2.2 Russia Peptide Cancer Vaccine Sales Market Share by Type (2013-2018) 10.3 Russia Peptide Cancer Vaccine Sales and Market Share by Application (2013-2018) 10.3.1 Russia Peptide Cancer Vaccine Sales by Application (2013-2018) 10.3.2 Russia Peptide Cancer Vaccine Sales Market Share by Application (2013-2018) 10.4 Russia Peptide Cancer Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017) 10.4.1 Russia Peptide Cancer Vaccine Sales and Market Share by Manufacturer (2016-2017) 10.4.2 Russia Peptide Cancer Vaccine Revenue and Market Share by Manufacturer (2016-2017) 10.5 Russia Peptide Cancer Vaccine Export and Import (2013-2018) 11 Italy Peptide Cancer Vaccine Sales, Revenue, by Type, Application and Manufacturers 11.1 Italy Peptide Cancer Vaccine Revenue, Sales and Growth Rate (2013-2018) 11.2 Italy Peptide Cancer Vaccine Sales and Market Share by Type (2013-2018) 11.2.1 Italy Peptide Cancer Vaccine Sales by Type (2013-2018) 11.2.2 Italy Peptide Cancer Vaccine Sales Market Share by Type (2013-2018) 11.3 Italy Peptide Cancer Vaccine Sales and Market Share by Application (2013-2018) 11.3.1 Italy Peptide Cancer Vaccine Sales by Application (2013-2018) 11.3.2 Italy Peptide Cancer Vaccine Sales Market Share by Application (2013-2018) 11.4 Italy Peptide Cancer Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017) 11.4.1 Italy Peptide Cancer Vaccine Sales and Market Share by Manufacturer (2016-2017) 11.4.2 Italy Peptide Cancer Vaccine Revenue and Market Share by Manufacturer (2016-2017) 11.5 Italy Peptide Cancer Vaccine Export and Import (2013-2018) 12 Peptide Cancer Vaccine Market Forecast (2018-2023) 12.1 Europe Peptide Cancer Vaccine Sales, Revenue and Growth Rate (2018-2023) 12.2 Peptide Cancer Vaccine Market Forecast by Countries (2018-2023) 12.2.1 Europe Peptide Cancer Vaccine Sales and Market Share Forecast by Countries (2018-2023) 12.2.2 Germany Peptide Cancer Vaccine Sales Forecast (2018-2023) 12.2.3 UK Peptide Cancer Vaccine Sales Forecast (2018-2023) 12.2.4 France Peptide Cancer Vaccine Sales Forecast (2018-2023) 12.2.5 Russia Peptide Cancer Vaccine Sales Forecast (2018-2023) 12.2.6 Italy Peptide Cancer Vaccine Sales Forecast (2018-2023) 12.3 Peptide Cancer Vaccine Market Forecast by Type (2018-2023) 12.3.1 Europe Peptide Cancer Vaccine Sales Forecast by Type (2018-2023) 12.3.2 Europe Peptide Cancer Vaccine Market Share Forecast by Type (2018-2023) 12.4 Peptide Cancer Vaccine Market Forecast by Application (2018-2023) 12.4.1 Europe Peptide Cancer Vaccine Sales Forecast by Application (2018-2023) 12.4.2 Europe Peptide Cancer Vaccine Market Share Forecast by Application (2018-2023) 13 Peptide Cancer Vaccine Manufacturing Cost Analysis 13.1 Peptide Cancer Vaccine Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Price Trend of Key Raw Materials 13.1.3 Key Suppliers of Raw Materials 13.1.4 Market Concentration Rate of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.2.1 Raw Materials 13.2.2 Labor Cost 13.2.3 Manufacturing Expenses 13.3 Manufacturing Process Analysis of Peptide Cancer Vaccine 14 Industrial Chain, Sourcing Strategy and Downstream Buyers 14.1 Peptide Cancer Vaccine Industrial Chain Analysis 14.2 Upstream Raw Materials Sourcing 14.3 Raw Materials Sources of Peptide Cancer Vaccine Major Manufacturers in 2017 14.4 Downstream Buyers 15 Sales Channel, Distributors, Traders and Dealers 15.1 Sales Channel 15.1.1 Direct Marketing 15.1.2 Indirect Marketing 15.1.3 Marketing Channel Future Trend 15.2 Distributors, Traders and Dealers 16 Research Findings and Conclusion 17 Appendix 17.1 Methodology 17.2 Data Source

List of Tables and Figures Figure Peptide Cancer Vaccine Picture Table Product Specifications of Peptide Cancer Vaccine Figure Europe Sales Market Share of Peptide Cancer Vaccine by Types in 2017 Table Types of Peptide Cancer Vaccine Figure Europe Peptide Cancer Vaccine Sales Market Share by Applications in 2017 Table Applications of Peptide Cancer Vaccine Figure Breast Cancer Picture Figure Lung Cancer Picture Figure Melanoma Picture Figure Prostate Cancer Picture Figure Others Picture Figure Germany Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2013-2023) Figure France Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2013-2023) Figure UK Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2013-2023) Figure Russia Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2013-2023) Figure Italy Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2013-2023) Table TapImmune Basic Information, Manufacturing Base and Competitors Table TapImmune Peptide Cancer Vaccine Type and Applications Table TapImmune Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table BrightPath Biotherapeutics Basic Information, Manufacturing Base and Competitors Table BrightPath Biotherapeutics Peptide Cancer Vaccine Type and Applications Table BrightPath Biotherapeutics Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Ultimovacs Basic Information, Manufacturing Base and Competitors Table Ultimovacs Peptide Cancer Vaccine Type and Applications Table Ultimovacs Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Sellas Basic Information, Manufacturing Base and Competitors Table Sellas Peptide Cancer Vaccine Type and Applications Table Sellas Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Boston Biomedical Basic Information, Manufacturing Base and Competitors Table Boston Biomedical Peptide Cancer Vaccine Type and Applications Table Boston Biomedical Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Imugene Basic Information, Manufacturing Base and Competitors Table Imugene Peptide Cancer Vaccine Type and Applications Table Imugene Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table VAXON Biotech Basic Information, Manufacturing Base and Competitors Table VAXON Biotech Peptide Cancer Vaccine Type and Applications Table VAXON Biotech Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Generex Biotechnology Basic Information, Manufacturing Base and Competitors Table Generex Biotechnology Peptide Cancer Vaccine Type and Applications Table Generex Biotechnology Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table ISA Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table ISA Pharmaceuticals Peptide Cancer Vaccine Type and Applications Table ISA Pharmaceuticals Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table OncoTherapy Science Basic Information, Manufacturing Base and Competitors Table OncoTherapy Science Peptide Cancer Vaccine Type and Applications Table OncoTherapy Science Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Immatics Basic Information, Manufacturing Base and Competitors Table Immatics Peptide Cancer Vaccine Type and Applications Table Immatics Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Europe Peptide Cancer Vaccine Sales by Manufacturer (2016-2017) Figure Europe Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2016 Figure Europe Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2017 Table Europe Peptide Cancer Vaccine Revenue by Manufacturer (2016-2017) Figure Europe Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2016 Figure Europe Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2017 Table Europe Peptide Cancer Vaccine Price by Manufacturers (2016-2017) Figure Top 3 Peptide Cancer Vaccine Manufacturer Market Share in 2016 Figure Top 3 Peptide Cancer Vaccine Manufacturer Market Share in 2017 Figure Top 5 Peptide Cancer Vaccine Manufacturer Market Share in 2016 Figure Top 5 Peptide Cancer Vaccine Manufacturer Market Share in 2017 Table Europe Peptide Cancer Vaccine Sales by Countries (2013-2018) Figure Europe Peptide Cancer Vaccine Sales and Growth Rate (2013-2018) Table Europe Peptide Cancer Vaccine Sales Market Share by Countries (2013-2018) Figure Europe 2013 Peptide Cancer Vaccine Sales Market Share by Countries Figure Europe 2017 Peptide Cancer Vaccine Sales Market Share by Countries Table Europe Peptide Cancer Vaccine Revenue by Countries (2013-2018) Figure Europe Peptide Cancer Vaccine Revenue and Growth Rate (2013-2018) Table Europe Peptide Cancer Vaccine Revenue Market Share by Countries (2013-2018) Table Europe 2013 Peptide Cancer Vaccine Revenue Market Share by Countries Table Europe 2017 Peptide Cancer Vaccine Revenue Market Share by Countries Table Europe Peptide Cancer Vaccine Sales by Type (2013-2018) Table Europe Peptide Cancer Vaccine Sales Share by Type (2013-2018) Table Europe Peptide Cancer Vaccine Revenue by Type (2013-2018) Table Europe Peptide Cancer Vaccine Revenue Share by Type (2013-2018) Table Europe Peptide Cancer Vaccine Sales by Application (2013-2018) Table Europe Peptide Cancer Vaccine Sales Share by Application (2013-2018) Figure Europe Breast Cancer Sales Growth (2013-2018) Figure Europe Lung Cancer Sales Growth (2013-2018) Figure Europe Melanoma Sales Growth (2013-2018) Figure Europe Prostate Cancer Sales Growth (2013-2018) Figure Europe Others Sales Growth (2013-2018) Figure Germany Peptide Cancer Vaccine Revenue and Growth Rate (2013-2018) Figure Germany Peptide Cancer Vaccine Sales and Growth Rate (2013-2018) Table Germany Peptide Cancer Vaccine Sales by Type (2013-2018) Table Germany Peptide Cancer Vaccine Sales Market Share by Type (2013-2018) Table Germany Peptide Cancer Vaccine Sales by Application (2013-2018) Table Germany Peptide Cancer Vaccine Sales Market Share by Application (2013-2018) Table Germany Peptide Cancer Vaccine Sales by Manufacturer (2016-2017) Figure Germany Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2016 Figure Germany Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2017 Table Germany Peptide Cancer Vaccine Revenue by Manufacturer (2016-2017) Figure Germany Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2016 Figure Germany Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2017 Table Germany Peptide Cancer Vaccine Export and Import (2013-2018) Figure UK Peptide Cancer Vaccine Revenue and Growth Rate (2013-2018) Figure UK Peptide Cancer Vaccine Sales and Growth Rate (2013-2018) Table UK Peptide Cancer Vaccine Sales by Type (2013-2018) Table UK Peptide Cancer Vaccine Sales Market Share by Type (2013-2018) Table UK Peptide Cancer Vaccine Sales by Application (2013-2018) Table UK Peptide Cancer Vaccine Sales Market Share by Application (2013-2018) Table UK Peptide Cancer Vaccine Sales by Manufacturer (2016-2017) Figure UK Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2016 Figure UK Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2017 Table UK Peptide Cancer Vaccine Revenue by Manufacturer (2016-2017) Figure UK Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2016 Figure UK Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2017 Table UK Peptide Cancer Vaccine Export and Import (2013-2018) Figure France Peptide Cancer Vaccine Revenue and Growth Rate (2013-2018) Figure France Peptide Cancer Vaccine Sales and Growth Rate (2013-2018) Table France Peptide Cancer Vaccine Sales by Type (2013-2018) Table France Peptide Cancer Vaccine Sales Market Share by Type (2013-2018) Table France Peptide Cancer Vaccine Sales by Application (2013-2018) Table France Peptide Cancer Vaccine Sales Market Share by Application (2013-2018) Table France Peptide Cancer Vaccine Sales by Manufacturer (2016-2017) Figure France Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2016 Figure France Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2017 Table France Peptide Cancer Vaccine Revenue by Manufacturer (2016-2017) Figure France Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2016 Figure France Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2017 Table France Peptide Cancer Vaccine Export and Import (2013-2018) Figure Russia Peptide Cancer Vaccine Revenue and Growth Rate (2013-2018) Figure Russia Peptide Cancer Vaccine Sales and Growth Rate (2013-2018) Table Russia Peptide Cancer Vaccine Sales by Type (2013-2018) Table Russia Peptide Cancer Vaccine Sales Market Share by Type (2013-2018) Table Russia Peptide Cancer Vaccine Sales by Application (2013-2018) Table Russia Peptide Cancer Vaccine Sales Market Share by Application (2013-2018) Table Russia Peptide Cancer Vaccine Sales by Manufacturer (2016-2017) Figure Russia Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2016 Figure Russia Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2017 Table Russia Peptide Cancer Vaccine Revenue by Manufacturer (2016-2017) Figure Russia Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2016 Figure Russia Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2017 Table Russia Peptide Cancer Vaccine Export and Import (2013-2018) Figure Italy Peptide Cancer Vaccine Revenue and Growth Rate (2013-2018) Figure Italy Peptide Cancer Vaccine Sales and Growth Rate (2013-2018) Table Italy Peptide Cancer Vaccine Sales by Type (2013-2018) Table Italy Peptide Cancer Vaccine Sales Market Share by Type (2013-2018) Table Italy Peptide Cancer Vaccine Sales by Application (2013-2018) Table Italy Peptide Cancer Vaccine Sales Market Share by Application (2013-2018) Table Italy Peptide Cancer Vaccine Sales by Manufacturer (2016-2017) Figure Italy Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2016 Figure Italy Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2017 Table Italy Peptide Cancer Vaccine Revenue by Manufacturer (2016-2017) Figure Italy Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2016 Figure Italy Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2017 Table Italy Peptide Cancer Vaccine Export and Import (2013-2018) Figure Europe Peptide Cancer Vaccine Sales, Revenue and Growth Rate (2018 -2023) Table Europe Peptide Cancer Vaccine Sales Forecast by Countries (2018-2023) Table Europe Peptide Cancer Vaccine Market Share Forecast by Countries (2018-2023) Figure Germany Peptide Cancer Vaccine Sales Forecast (2018-2023) Figure UK Peptide Cancer Vaccine Sales Forecast (2018-2023) Figure France Peptide Cancer Vaccine Sales Forecast (2018-2023) Figure Russia Peptide Cancer Vaccine Sales Forecast (2018-2023) Figure Italy Peptide Cancer Vaccine Sales Forecast (2018-2023) Table Europe Peptide Cancer Vaccine Sales Forecast by Type (2018-2023) Table Europe Peptide Cancer Vaccine Market Share Forecast by Type (2018-2023) Table Europe Peptide Cancer Vaccine Sales Forecast by Application (2018-2023) Table Europe Peptide Cancer Vaccine Market Share Forecast by Application (2018-2023) Table Sales Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Peptide Cancer Vaccine Figure Manufacturing Process Analysis of Peptide Cancer Vaccine Figure Peptide Cancer Vaccine Industrial Chain Analysis Table Raw Materials Sources of Peptide Cancer Vaccine Major Manufacturers in 2017 Table Major Buyers of Peptide Cancer Vaccine Table Distributors/Traders/ Dealers List